Cancer News -- ScienceDaily
WEBRead the latest medical research on risk factors for cancer, cancer symptoms, treatments and more. Updated daily.
An experimental cancer drug had a 100% success rate : NPR
WEBJun 7, 2022 · A tiny group of people with rectal cancer just experienced something of a scientific miracle: their cancer simply vanished after an experimental treatment.
Cancer News - Health News, Medicine News, Cancer - Medical Xpress
WEB5 days ago · The latest news on cancer, health, medicines, cancer treatments, cancer research, cancer studies and types of cancer.
News & Events - NCI - National Cancer Institute
WEBJul 11, 2024 · The latest cancer news from the US government's principal agency for cancer research, plus resources designed for science writers and reporters.
Cancer News and Stories - American Cancer Society
WEB6 days ago · Cancer News and Stories. Our team of experts brings you cancer-related news, features, and survivor stories. For the latest news about research we conduct and fund, see ACS Research News.
Aggressive colon cancer: Newly identified bacteria found in ... - NBC News
WEBA newly identified subspecies of bacteria may drive aggressive colon cancer growth. Does the bacteria play a role in the surge in cases in younger adults? Scientists discovered that a common type...
Lung cancer survival rates are up thanks to immunotherapy, other ... - NPR
WEBApr 12, 2024 · Lung cancer remains the most lethal form of the disease, killing about 135,000 Americans a year – more than breast, prostate and colon cancer combined – which is why many people still think of a...
FDA approves groundbreaking treatment for advanced melanoma - NBC News
WEBFeb 16, 2024 · The Food and Drug Administration on Friday approved a new cancer therapy that could one day transform the way a majority of aggressive and advanced tumors are treated.
Lifileucel First Cellular Therapy Approved for Cancer
WEBMar 5, 2024 · In an event more than three decades in the making, the Food and Drug Administration (FDA) has approved lifileucel (Amtagvi), the first treatment for cancer that uses immune cells called tumor-infiltrating lymphocytes, or TILs.
New study finds triple-negative breast cancer tumors with an …
WEBApr 25, 2024 · A new multicenter, international study suggests that people who have early-stage triple-negative breast cancer (TNBC) and high levels of immune cells within their tumors may have a lower risk of recurrence and better survival rates even when not treated with chemotherapy.